DePuy Synthes expands portfolio with nerve assessment platform: 4 things to know

DePuy Synthes, a Johnson & Johnson company, launched Sentio MMG, a digital mechanomyography platform designed to assess nerve status.

Advertisement

Here are four things to know:

1. The platform is also designed to identify and avoid peripheral nerves during spine surgery. It can be used during non-fusion procedures as well as minimally invasive and open spinal fusion operations.

2. Sentio MMG features a touchscreen tablet, control unit, probes and smart sensors that minimizes staff in the operating room.

3. The patented, smart sensor technology provides surgeons with real-time feedback on nerve location through visual and audible alerts.

4. DePuy Synthes is introducing the technology at the North American Spine Society Annual Meeting in Los Angeles, Sept. 26-29.

More articles on devices and implants:
Gramercy Extremity Orthopedics earns variable angle locking technology patent: 3 insights
1st FDA-cleared nanotextured PEEK spinal implant may improve outcomes
How active hinge tables can lead to better spine surgery outcomes

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.